Vimarsana
Biggest News Aggregation in the World

Page 17 - Des Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Des Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Des Sciences Today - Breaking & Trending Today

AB Science announces the signing of an exclusive licensing agreement with the University of ... - Vimarsana News

AB Science announces the signing of an exclusive licensing agreement with the University of ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AB Science announces the signing of an exclusive licensing agreement with the University of ... AB ScienceApril 6, 2021 GMT                                                                                                                                                                                                                                                              ...

Source: apnews.com
What is the right way to say 'Mars landing' in French - Vimarsana News

What is the right way to say 'Mars landing' in French

atterrissage to any neologism. In 2012, L'Académie ruled that the term atterrissage, which is sometimes assumed to reference planet Earth, in fact refers to the element earth - and as such does not have its root in a proper noun. As such, atterrissage is defined as the act of landing on ground - in which case, the location of the landing ground in question - Mars or Terran - is unimportant. The Académie des Sciences, meanwhile, "does not recognise the term amarsissage," for the specific act of landing on Mars, according to Le Figaro. As astrophysicist Francis Rocard told LCI in 2018: "T...

Adrienne Engono Epse Moussang - Vimarsana News

Adrienne Engono Epse Moussang

Rainforest Congo Basin Mrs. Adrienne Engono Epse Moussang has worked as a journalist in Cameroon since 2002, following three years of studies at the Ecole supérieure des Sciences et Techniques de l'Information et de la Communication (Esstic) at the University of Yaoundé II. She is responsible for the Health-Environment section at Mutations (http://www.quotidienmutations.cm), a daily newspaper based in Yaoundé, which covers science, health, climate change, forests, agriculture, and mining.  In 2015, after attending a training course organized by the World Health Organization (WHO) and th...

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non-Human Primates - Vimarsana News

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non-Human Primates

GenSight Biologics Announces the Publication in Communications Biology of the Proof-of-Concept for GS030-Drug Product in Non-Human Primates The ex vivo retinal stimulation assays also showed that the electrophysiologic response of RGCs expressing ChrimsonR precisely followed the duration and frequency of the light pulses used to activate the opsin. Moreover, localized stimulation of RGCs induced a response coherent with the size and position of the light pulses. Optogenetic stimulation of RGCs expressing ChrimsonR-tdT can support restoration of visual acuity The electrophysiological activity...

Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across ... - Vimarsana News

Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Innate Pharma to Host Key Opinion Leader Discussion on the Potential Role of Lacutamab Across ... INNATE PHARMAFebruary 3, 2021 GMT MARSEILLE, France, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that it will host a virtual key opinion leader (KOL) discussion focused on the potential role of its lead investigational drug candidate, lacutamab, an anti-KIR3DL2 cytotoxicity-inducing anti...

Source: apnews.com